We interrogated single cell data from a robust, publicly available dataset of spatially resolved human breast cancers [33] to ascertain if the observed gene signatures from our patient-derived CD90+ MSCs were unique to MSCs or could be observed in other cells composing the tumor microenvironment. This evidence concerns the gene THY1 and neoplasm.